Centogene NV (CNTG) - יחס מהיר

Centogene N.V. is developing digital biodata processing systems to identify rare pathologies, expanding its partnerships with the pharmaceutical sector through the full automation of DNA and blood analysis. This price chart featuring the 0.00 indicator clearly illustrates the asset's price action. The company's operations rely on strict biomaterial disposal regulations and standard environmental office norms.

Quick liquidity determines a company's ability to instantaneously settle short-term obligations without liquidating inventory. The current critical coverage ratio stands at 0.00, reflecting the balance between financial stability and capital efficiency. The calculation is based exclusively on cash and accounts receivable, excluding low-liquidity assets. For Centogene N.V. (CNTG), such solvency is critical when scaling diagnostic services and expanding partnerships with pharma behemoths.